AorTech seals first major supply deal for Elast-Eon parts
This article was originally published in Clinica
AorTech International, the AIM-listed developer of biostable polymers for medical device applications, has secured its first large-scale licence and supply agreement for medical device components made from its silicone-urethane co-polymer Elast-Eon. The unnamed customer will use the components in its heart-assist device. In return, AorTech will receive upfront and volume-related payments, as well as provisions for polymer and component sales. Shipments of the Elast-Eon components are expected to begin in the first quarter of 2009. The UK-based company said these supply agreements for Elast-Eon-made components have significantly higher revenue potential than those for the material only. Industry consensus estimates that the worldwide market for heart-assist devices could reach $8-10bn in the next 10 years.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.